Unknown

Dataset Information

0

Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.


ABSTRACT: BACKGROUND:Cognitive impairment (CI) profoundly impacts quality of life for patients with multiple sclerosis (MS). Dysfunctional regulation of glutamate in gray matter (GM) has been implicated in the pathogenesis of MS by post-mortem pathological studies and in CI by in vivo magnetic resonance spectroscopy, yet GM pathology is subtle and difficult to detect using conventional T1- and T2-weighted magnetic resonance imaging (MRI). There is a need for high-resolution, clinically accessible imaging techniques that probe molecular changes in GM. OBJECTIVE:To study cortical GM pathology related to CI in MS using glutamate-sensitive chemical exchange saturation transfer (GluCEST) MRI at 7.0?Tesla (7T). METHODS:A total of 20 patients with relapsing-remitting MS and 20 healthy controls underwent cognitive testing, anatomical imaging, and GluCEST imaging. Glutamate-sensitive image contrast was quantified for cortical GM, compared between cohorts, and correlated with clinical measures of CI. RESULTS AND CONCLUSION:Glutamate-sensitive contrast was significantly increased in the prefrontal cortex of MS patients with accumulated disability (p?

SUBMITTER: O'Grady KP 

PROVIDER: S-EPMC6424643 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.

O'Grady Kristin P KP   Dula Adrienne N AN   Lyttle Bailey D BD   Thompson Lindsey M LM   Conrad Benjamin N BN   Box Bailey A BA   McKeithan Lydia J LJ   Pawate Siddharama S   Bagnato Francesca F   Landman Bennett A BA   Newhouse Paul P   Smith Seth A SA  

Multiple sclerosis (Houndmills, Basingstoke, England) 20180919 12


<h4>Background</h4>Cognitive impairment (CI) profoundly impacts quality of life for patients with multiple sclerosis (MS). Dysfunctional regulation of glutamate in gray matter (GM) has been implicated in the pathogenesis of MS by post-mortem pathological studies and in CI by in vivo magnetic resonance spectroscopy, yet GM pathology is subtle and difficult to detect using conventional T<sub>1</sub>- and T<sub>2</sub>-weighted magnetic resonance imaging (MRI). There is a need for high-resolution,  ...[more]

Similar Datasets

| S-EPMC3523869 | biostudies-other
| S-EPMC6393954 | biostudies-literature
| S-EPMC7818856 | biostudies-literature
| S-EPMC7902024 | biostudies-literature
| PRJNA827227 | ENA
| S-EPMC3223469 | biostudies-literature
| S-EPMC5712315 | biostudies-literature
| S-EPMC5344745 | biostudies-literature
| S-EPMC8673326 | biostudies-literature
| S-EPMC5399449 | biostudies-literature